Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3979088 | Bulletin du Cancer | 2012 | 7 Pages |
Abstract
Granulocyte colony-stimulating factor (G-CSF) are frequently used in oncology and haematology practice. Respiratory disturbance has been reported during administration of G-CSF. G-CSF may induce pulmonary toxicity but this fact remains an open debate because of its frequent association with other drugs. The action of these treatments could explain a part of the pulmonary events but not completely. The specific pulmonary effect of the G-CSF is probably underestimated. Most of these pulmonary events occur in association with other risk factors, mainly when a pneumonia occurs during the neutropenia. However, G-CSF are recommended in febrile neutropenia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ãlise Noël-Savina, Renaud Descourt,